Comparison of Four Food and Drug Administration–Approved Mechanical Thrombectomy Devices for Acute Ischemic Stroke: A Network Meta-Analysis
- 1 July 2019
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 127, e49-e57
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81620108009)
- Ministry of Science and Technology of the People's Republic of China (2016YFC1300500-505)
- Science and Technology Department of Sichuan Province (2017SZ0007)
- National Basic Research Program of China
This publication has 33 references indexed in Scilit:
- Stentrievers versus other endovascular treatment methods for acute stroke: comparison of procedural results and their relationship to outcomesJournal of NeuroInterventional Surgery, 2013
- Stent-Based Thrombectomy Versus Intravenous Tissue Plasminogen Activator in Patients With Acute Middle Cerebral Artery OcclusionStroke, 2012
- Comparison of Stent-Retriever Devices versus the Merci Retriever for Endovascular Treatment of Acute StrokeAmerican Journal of Neuroradiology, 2012
- Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studiesResearch Synthesis Methods, 2012
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Good clinical outcome after ischemic stroke with successful revascularization is time-dependentNeurology, 2009
- Mechanical Thrombectomy for Acute Ischemic StrokeStroke, 2008
- Recanalization after thrombolysis in stroke patientsNeurology, 2007
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004